Diagnosis (Laboratory)

(Unterschied zwischen Versionen)

Wechseln zu: Navigation, Suche

Version vom 26. Juni 2020, 10:21 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Diagnosis (Laboratory other parameters)
Dx PCR
Dx Antigen
Dx Antibodies
Dx Serology all the imbecile titles not showing what they intend to test
Dx Lab. various methods reviews, n>2 comparisons, intermodality comparisons
Dx Lab. unconventional methods
Dx which matrix how to obtain, which to use

32077933 ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak
32154877 ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception

32353116 ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything

32315390 ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform
32282874 ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2)

32229107 2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient
32031583 ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
32156607 ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020

32335089 ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories

32358960 ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools

32306042 ä. Testing for SARS-CoV-2: Can We Stop at Two?
32276116 ä. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay
32306036 ä. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients

32197339 2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19

32294051 2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2

32306853 2020. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2

32102625 2020. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity

32329811 2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov
32156329 2020. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system
31992387 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

32290902 2020. An alternative workflow for molecular detection of SARS-CoV-2 escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020
32290904 2020. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020
32156101 2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)
32297805 2020. Real-time RT-PCR in COVID-19 detection: issues affecting the results

32242876 2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India

32370065 2020. Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
32344568 2020. RT-qPCR Testing of SARS-CoV-2: A Primer
32276333 2020. Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens
32325642 2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2

32341142 2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection

32132196 2020. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens

32361322 2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus
32361324 ä. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study
32302956 2020. Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT

32360885 ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients

32276051 ä. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2
32292623 2020. Recent advances and perspectives of nucleic acid detection for coronavirus
32352933 2020. Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China

32074516 2020. Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan
32350226 2020. An assessment of real-time RT-PCR kits for SARS-CoV-2 detection
32266524 ä. A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT
32207257 2020. A Patient with COVID-19 Presenting a False-Negative Reverse Transcriptase Polymerase Chain Reaction Result

32224308 ä. Understanding COVID-19: what does viral RNA load really mean?

32217609 2020. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS?CoV-2/COVID-19
32361529 ä. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19

32333644 2020. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2

32074444 2020. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

32358057 2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection

32327566 2020. One ventilator for two patients: feasibility and considerations of a last resort solution in case of equipment shortage
32378843 2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover

32283215 ä. False negative rate of COVID-19 is eliminated by using nasal swab test
32239445 ä. Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2

32293905 2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients

32338536 2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR)

32221132 2020. In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic variation on published real-time quantitative polymerase chain reaction detection assays

32149771 2020. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days

32242829 2020. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients

32311826 2020. COVID-19 and the clinical hematology laboratory

32222993 ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy

32096564 ä. Combination of RT?qPCR testing and clinical features for diagnosis of COVID?19 facilitates management of SARS?CoV?2 outbreak

32270882 2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence

32271278 2020. Integrated Radiologic Algorithm for COVID-19 Pandemic

32334422 2020. Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract

32223871 2020. Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department

32387093 2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences

32378133 ä. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai, India

32416598 2020. SARS-CoV-2 detection by direct rRT-PCR without RNA extraction

32388470 2020. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa? COVID-19 direct assay

32403009 2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet
32403008 2020. A RT-PCR assay for the detection of coronaviruses from four genera
32388472 2020. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China

32388471 2020. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting

32006218 ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia

32248474 2020. Vergessen Sie die Schnellteste auf Coronavirus!
32342388 2020. Anwendung von Antikörper-Schnelltests ist Körperverletzung: Dr Matthias Orth
32372836 2020. The problems with so-called immunity tests
32376476 ä. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident

32149770 2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction

32396505 2020. US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.

32448084 2020. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets.
32438868 2020. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens.
32505692 2020. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.
32492531 2020. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.

32505778 2020. Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19.
32512376 2020. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification.

32459081 2020. Evaluacion de diferentes genes en la deteccion por RT-PCR del SARS-CoV-2 en muestras respiratorias y su evolucion en la infeccion.

32329388 2020. Positive RT-PCR test results after consecutively negative results in patients with COVID-19.

32474555 2020. Evaluation of RdRp & ORF-1b-nsp14-based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study.

32423519 2020. Screening for COVID-19: Patient Factors Predicting Positive PCR Test.

32449639 2020. SARS-CoV-2 RT-PCR: at least 2 viral targets are needed.
32420777 2020. Positive RT-PCR in urine from an asymptomatic patient with novel coronavirus 2019 infection: a case report.
32501535 2020. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.
32484950 2020. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.

32475012 2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.

32506118 2020. Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.
32504529 2020. Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity?

32472672 2020. What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?

32435816 2020. To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value.
32320539 2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.

32401598 2020. COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?
32401535 2020. Reply to: COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?

32270938 2020. Performance du frottis nasopharynge-PCR pour le diagnostic du Covid-19 - Recommandations pratiques sur la base des premieres donnees scientifiques.

32483586 2020. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.

32461287 2020. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2.
32461285 2020. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.
32444354 2020. Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.

32381643 2020. Comparison of Two High-Throughput Reverse Transcription-Polymerase Chain Reaction Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.
32381642 2020. Understanding, verifying and implementing Emergency Use Authorization molecular diagnostics for the detection of SARS-CoV-2 RNA.
32471894 2020. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution.

008

32469511 2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?

32528710 2020. Persistence of positive severe acute respiratory syndrome coronavirus-2 reverse transcription-polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier.

32438806 2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.
32395391 2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.

32387502 2020. Reduced Physical Activity During COVID-19 Pandemic in Children With Congenital Heart Disease.

32427226 2020. An automated Residual Exemplar Local Binary Pattern and iterative ReliefF based corona detection method using lung X-ray image.

32384153 2020. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ).

32422410 2020. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA.

{{tp|p=32502646|t=2020. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.|pdf=|usr=008

32444479 2020. Incidental COVID-19 on PET/CT imaging.

32530490 2020. A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.

32441935 2020. A Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2).
32490854 2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.

32515793 2020. Why, when, and how to use lung ultrasound during the COVID-19 pandemic: enthusiasm and caution.
32527161 2020. How Fear Appeal Approaches in COVID-19 Health Communication May Be Harming the Global Community.
32533803 2020. The Covid-19 'infodemic': a new front for information professionals.
32522311 2020. RT-PCR tests for SARS-CoV-2 processed at a large Italian Hospital and false-negative results among confirmed COVID-19 cases.

32530790 2020. Ellen Grass Lecture: Wellness for Allied Healthcare Professionals in the Age of COVID-19.

32489177 2020. Authors' response: SARS-CoV-2 detection by real-time RT-PCR.
32489175 2020. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR.

32452225 2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.

32535302 2020. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.

32531884 2020. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.
32098019 2020. Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).

32281158 2020. The pandemic paradox: The consequences of COVID-19 on domestic violence.
32344460 2020. The potential for COVID-19 to contribute to compassion fatigue in critical care nurses.
32320509 2020. Covid-19: Supporting nurses' psychological and mental health.
32535398 2020. Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2.

32504943 2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.

32535397 2020. Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR.

32344319 2020. Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples.
32485473 2020. Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies.
32474371 2020. Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity.
32460173 2020. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay.

32416600 2020. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.

32405254 2020. Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories.

32446722 2020. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection.

32173458 2020. Experience of different upper respiratory tract sampling strategies for detection of COVID-19.

32473233 2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.
32473229 2020. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.

32383182 2020. Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?
32383179 2020. Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test.

32401374 2020. Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.

32496708 2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?
32536002 2020. Pitfalls in SARS-CoV-2 PCR diagnostics.

Diagnosis (Laboratory)

Version vom 26. Juni 2020, 10:21 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

008

Meine Werkzeuge

Namensräume

Varianten

Ansichten

Aktionen

Suche

Navigation

Werkzeuge

@@ Zeile 14: / Zeile 14: @@
-{{tp|p=32282894|t=ä. Diagnostic Testing for Severe Acute Respiratory Syndrome?Related Coronavirus-2: A Narrative Review |pdf=|usr=}}
-*[https://archive.fo/61OpY on false-positives]
-*[https://www.aljazeera.com/news/2020/05/tanzania-covid-19-lab-head-suspended-president-questions-data-200505065136872.html on positives in non-vertebrate samples]
-{{tp|p=32293168|t=ä. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal  Swab Specimens Using Field-Effect Transistor-Based Biosensor |pdf=|usr=}}
-{{tp|p=32223179|t=ä. Diagnosing COVID-19: The Disease and Tools for Detection |pdf=|usr=}}
-{{tp|p=32281785|t=ä. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection |pdf=|usr=}}
-{{tp|p=32304208|t=ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources |pdf=|usr=}}
-{{tp|p=32227199|t=ä. SARS-CoV-2 Testing: Trials and Tribulations |pdf=|usr=}}
-{{tp|p=Cä|t=Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.|pdf=http://europepmc.org/articles/PMC7169629?pdf=render|usr=}}
-{{tp|p=32259132|t=2020. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study  |pdf=|usr=}}
-{{tp|p=32331788|t=ä. Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32290684|t=2020. Exhaled breath condensate as a potential specimen for diagnosing COVID-19 |pdf=|usr=}}
-{{tp|p=32364936|t=2020. Electrochemical biosensors for pathogen detection |pdf=|usr=}}
-{{tp|p=32330437|t=ä. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil |pdf=|usr=}}
-{{tp|p=32360478|t=2020. Emerging key laboratory tests for patients with COVID-19 |pdf=|usr=}}
 {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health  Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}}
 {{tp|p=32154877|t=ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception |pdf=|usr=}}
-{{tp|p=32246822|t=ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low  viral loads |pdf=|usr=}}
 {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}}
 {{tp|p=32315390|t=ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform |pdf=|usr=}}
 {{tp|p=32282874|t=ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2  (SARS-CoV-2) |pdf=|usr=}}
-{{tp|p=32031590|t=ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV) |pdf=|usr=}}
 {{tp|p=32229107|t=2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient |pdf=|usr=}}
 {{tp|p=32031583|t=ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia |pdf=|usr=}}
@@ Zeile 46: / Zeile 43: @@
 {{tp|p=32335089|t=ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |pdf=|usr=}}
-{{tp|p=32315614|t=2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients |pdf=|usr=}}
-{{tp|p=32295319|t=2020. Innovative screening tests for COVID-19 in South Korea |pdf=|usr=}}
-{{tp|p=32358960|t=ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools |pdf=|usr=}}
-{{tp|p=32221523|t=ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients |pdf=|usr=}}
+{{tp|p=32358960|t=ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools |pdf=|usr=}}
-{{tp|p=32047895|t=ä. Consistent Detection of 2019 Novel Coronavirus in Saliva |pdf=|usr=}}
-{{tp|p=32271374|t=ä. Effect of throat washings on detection of 2019 novel coronavirus |pdf=|usr=}}
-{{tp|p=32241023|t=ä. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan |pdf=|usr=}}
 {{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
@@ Zeile 63: / Zeile 55: @@
-{{tp|p=32313785|t=ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19 |pdf=|usr=}}
 {{tp|p=32197339|t=2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19 |pdf=|usr=}}
-{{tp|p=32260471|t=2020. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends |pdf=|usr=}}
-{{tp|p=32316113|t=2020. Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic |pdf=|usr=}}
-{{tp|p=32244841|t=2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing |pdf=|usr=}}
 {{tp|p=32294051|t=2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
-{{tp|p=32273299|t=2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic |pdf=|usr=}}
-{{tp|p=32306864|t=2020. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients |pdf=|usr=}}
-{{tp|p=32196430|t=2020. Laboratory diagnosis of emerging human coronavirus infections - the state of the  art |pdf=|usr=}}
-{{tp|p=32207377|t=2020. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 |pdf=|usr=}}
 {{tp|p=32306853|t=2020. Development of a reverse transcription-loop-mediated isothermal amplification as  a rapid early-detection method for novel SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32174267|t=2020. Era of molecular diagnosis for pathogen identification of unexplained pneumonia,  lessons to be learned |pdf=|usr=}}
 {{tp|p=32102625|t=2020. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity |pdf=|usr=}}
-{{tp|p=32065057|t=2020. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes |pdf=|usr=}}
-{{tp|p=32020836|t=2020. RNA based mNGS approach identifies a novel human coronavirus from two individual  pneumonia cases in 2019 Wuhan outbreak |pdf=|usr=}}
-{{tp|p=32270412|t=ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32342252|t=ä. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards |pdf=|usr=}}
 {{tp|p=32329811|t=2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov |pdf=|usr=}}
 {{tp|p=32156329|t=2020. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system |pdf=|usr=}}
-{{tp|p=32209163|t=2020. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |pdf=|usr=}}
-{{tp|p=32156330|t=2020. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 |pdf=|usr=}}
 {{tp|p=31992387|t=2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR |pdf=|usr=}}
-{{tp|p=32046815|t=2020. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020 |pdf=|usr=}}
 {{tp|p=32290902|t=2020. An alternative workflow for molecular detection of SARS-CoV-2 escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020 |pdf=|usr=}}
@@ Zeile 98: / Zeile 80: @@
 {{tp|p=32297805|t=2020. Real-time RT-PCR in COVID-19 detection: issues affecting the results |pdf=|usr=}}
-{{tp|p=32377507|t=ä. A Cautionary Tale of False-Negative Nasopharyngeal COVID-19 Testing |pdf=|usr=}}
 {{tp|p=32242876|t=2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India |pdf=|usr=}}
-{{tp|p=32342674|t=2020. Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening |pdf=|usr=}}
-{{tp|p=32007627|t=2020. Novel coronavirus: From discovery to clinical diagnostics |pdf=|usr=}}
-{{tp|p=32304994|t=ä. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients |pdf=|usr=}}
-{{tp|p=32224986|t=2020. Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV) |pdf=|usr=}}
-{{tp|p=32371192|t=ä. Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus |pdf=|usr=}}
-{{tp|p=32344011|t=2020. Mild versus severe COVID-19: Laboratory markers |pdf=|usr=}}
-{{tp|p=32315809|t=ä. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in  353 patients received tests with both specimens simultaneously |pdf=|usr=}}
-{{tp|p=32114193|t=2020. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests |pdf=|usr=}}
 {{tp|p=32370065|t=2020. Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
 {{tp|p=32344568|t=2020. RT-qPCR Testing of SARS-CoV-2: A Primer |pdf=|usr=}}
@@ Zeile 116: / Zeile 96: @@
 {{tp|p=32325642|t=2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
-{{tp|p=32269100|t=2020. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit |pdf=|usr=}}
-{{tp|p=32350048|t=2020. Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories |pdf=|usr=}}
-{{tp|p=32341143|t=2020. Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens |pdf=|usr=}}
 {{tp|p=32341142|t=2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection |pdf=|usr=}}
-{{tp|p=32341141|t=2020. Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR |pdf=|usr=}}
-{{tp|p=32332061|t=2020. Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2 |pdf=|usr=}}
 {{tp|p=32132196|t=2020. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens |pdf=|usr=}}
-{{tp|p=32102856|t=2020. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19 |pdf=|usr=}}
-{{tp|p=32317257|t=2020. Saliva as a non-invasive specimen for detection of SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32317256|t=2020. Validation of the Hologic s Aptima Unisex and Multitest Specimen collection kits  used for Endocervical and Male Urethral Swab Specimen (Aptima Swab) for sample collection of SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32303564|t=2020. Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 |pdf=|usr=}}
-{{tp|p=32295896|t=2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage |pdf=|usr=}}
@@ Zeile 138: / Zeile 111: @@
 {{tp|p=32361324|t=ä. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a  descriptive study |pdf=|usr=}}
 {{tp|p=32302956|t=2020. Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT |pdf=|usr=}}
-{{tp|p=32328218|t=ä. Salivary diagnostics in COVID-19: Future research implications |pdf=|usr=}}
 {{tp|p=32360885|t=ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients |pdf=|usr=}}
-{{tp|p=32298676|t=ä. Saliva is a reliable tool to detect SARS-CoV-2 |pdf=|usr=}}
-{{ttp|p=31944312|t=2020. Recent advances in the detection of respiratory virus infection in humans |pdf=|usr=}}
 {{tp|p=32276051|t=ä. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2 |pdf=|usr=}}
 {{tp|p=32292623|t=2020. Recent advances and perspectives of nucleic acid detection for coronavirus |pdf=|usr=}}
-{{tp|p=32159775|t=2020. Detection of SARS-CoV-2 in Different Types of Clinical Specimens |pdf=|usr=}}
-{{tp|p=32250394|t=2020. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2 |pdf=|usr=}}
 {{tp|p=32352933|t=2020. Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic  acid tests from Wuhan, China |pdf=|usr=}}
@@ Zeile 156: / Zeile 127: @@
 {{tp|p=32266524|t=ä. A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT |pdf=|usr=}}
 {{tp|p=32207257|t=2020. A Patient with COVID-19 Presenting a False-Negative Reverse Transcriptase Polymerase Chain Reaction Result |pdf=|usr=}}
-{{tp|p=32341519|t=ä. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia |pdf=|usr=}}
-{{tp|p=32224308|t=ä. Understanding COVID-19: what does viral RNA load really mean?|pdf=|usr=}}
-{{tp|p=32342928|t=2020. Upper respiratory tract sampling in COVID-19 |pdf=|usr=}}
+{{ttp|p=32224308|t=ä. Understanding COVID-19: what does viral RNA load really mean?|pdf=|usr=}}
 {{tp|p=32217609|t=2020. Report from the American Society for Microbiology COVID-19 International Summit,  23 March 2020: Value of Diagnostic Testing for SARS?CoV-2/COVID-19 |pdf=|usr=}}
@@ Zeile 166: / Zeile 137: @@
 {{tp|p=32333644|t=2020. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32183357|t=2020. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics |pdf=|usr=}}
-{{tp|p=32106462|t=2020. Disposable DNA Amplification Chips with Integrated Low-Cost Heaters ? |pdf=|usr=}}
 {{tp|p=32074444|t=2020. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients |pdf=|usr=}}
-{{tp|p=C7187661|t=ä. Group Testing for SARS-CoV-2: Forward to the Past?|pdf=|usr=}}
 {{ttp|p=32358057|t=2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection |pdf=|usr=}}
-{{ttp|p=32373393|t=ä. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER |pdf=|usr=}}
 {{tp|p=32327566|t=2020. One ventilator for two patients: feasibility and considerations of a last resort  solution in case of equipment shortage |pdf=|usr=}}
 {{tp|p=32378843|t=2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover |pdf=|usr=}}
-{{tp|p=32311437|t=ä. Detection and analysis of nucleic acid in various biological samples of COVID-19  patients |pdf=|usr=}}
 {{tp|p=32283215|t=ä. False negative rate of COVID-19 is eliminated by using nasal swab test |pdf=|usr=}}
 {{tp|p=32239445|t=ä. Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32293905|t=2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients |pdf=|usr=}}
+{{ttp|p=32293905|t=2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients |pdf=|usr=}}
 {{tp|p=32338536|t=2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR) |pdf=|usr=}}
-{{tp|p=32367615|t=2020. Trends and Innovations in Biosensors for COVID-19 Mass Testing |pdf=|usr=}}
-{{ttp|p=32187837|t=2020. Supersensitive Multifluorophore RNA-FISH for Early Virus Detection and Flow-FISH  by Using Click Chemistry |pdf=|usr=}}
 {{ttp|p=32221132|t=2020. In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic  variation on published real-time quantitative polymerase chain reaction detection assays |pdf=|usr=}}
 {{tp|p=32149771|t=2020. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days |pdf=|usr=}}
-{{tp|p=32191623|t=2020. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks |pdf=|usr=}}
-{{tp|p=32172228|t=2020. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
-{{tp|p=32242831|t=2020. Clinical laboratory and SARS-CoV-2 infection: where do we stand?|pdf=|usr=}}
 {{tp|p=32242829|t=2020. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients |pdf=|usr=}}
-{{tp|p=32301748|t=2020. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation |pdf=|usr=}}
-{{tp|p=32301745|t=2020. Comparison of throat swabs and sputum specimens for viral nucleic acid detection  in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19) |pdf=|usr=}}
-{{tp|p=32286242|t=2020. The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019 |pdf=|usr=}}
-{{ttp|p=32378969|t=2020. Spectroscopy as a tool for detection and monitoring of Coronavirus (COVID-19) |pdf=|usr=}}
-{{ttp|p=32357381|t=2020. Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview |pdf=|usr=}}
-{{tp|p=32329102|t=2020. Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment |pdf=|usr=}}
-{{tp|p=32295895|t=2020. Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage |pdf=|usr=}}
-{{tp|p=32380382|t=ä. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays |pdf=|usr=}}
-{{ttp|p=32357377|t=2020. Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes |pdf=|usr=}}
-{{ttp|p=32352180|t=2020. COVID-19: Nasal and oropharyngeal swab |pdf=|usr=}}
-{{tp|p=32329138|t=2020. Who should perform the rhinopharyngeal swab in COVID-19 positive patients?|pdf=|usr=}}
-{{tp|p=32356761|t=2020. Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management |pdf=|usr=}}
 {{ttp|p=32311826|t=2020. COVID-19 and the clinical hematology laboratory |pdf=|usr=}}
-{{ttp|p=32245835|t=2020. Laboratory Diagnosis of COVID-19: Current Issues and Challenges |pdf=|usr=}}
-{{tp|p=32349033|t=2020. Novel biosensor platforms for the detection of coronavirus infection and SARS-CoV-2 |pdf=|usr=}}
@@ Zeile 220: / Zeile 183: @@
 {{tp|p=32270882|t=2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence |pdf=|usr=}}
-{{tp|p=32347966|t=2020. An Evolving Approach to the Laboratory Assessment of COVID-19 |pdf=|usr
-{{ttp|p=32297981|t=2020. COVID-19: Recommended sampling sites at different stage of the disease |pdf=|usr=}}
 {{tp|p=32271278|t=2020. Integrated Radiologic Algorithm for COVID-19 Pandemic |pdf=|usr=}}
-{{ttp|p=32374370|t=2020. Interpreting Diagnostic Tests for SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32367861|t=2020. Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test |pdf=|usr=}}
-{{tp|p=32236503|t=2020. Testing Individuals for Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 {{tp|p=32334422|t=2020. Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract |pdf=|usr=}}
-{{tp|p=32171389|t=2020. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients |pdf=|usr=}}
-{{ttp|p=32300245|t=2020. CRISPR-Cas12-based detection of SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32273607|t=2020. Virological assessment of SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32235945|t=2020. Virological assessment of hospitalized patients with COVID-2019 |pdf=|usr=}}
-{{tp|p=32311181|t=2020. SARS-CoV-2: What can saliva tell us?|pdf=|usr=}}
-{{tp|p=32302058|t=2020. Laboratory testing of SARS?CoV, MERS?CoV, and SARS?CoV?2 (2019?nCoV): Current status, challenges, and countermeasures |pdf=|usr=}}
-{{tp|p=32179122|t=2020. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?|pdf=|usr=}}
-{{tp|p=32380210|t=ä. The Impacts of Viral Inactivating Methods On Quantitative RT-PCR for COVID-19 |pdf=|usr=}}
-{{ttp|p=32302278|t=2020. The Appropriate Use of Testing for COVID-19 |pdf=|usr=}}
 {{tp|p=32223871|t=2020. Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department |pdf=|usr=}}
-{{tp|p=C7200353|t=2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection |pdf=|usr=}}
-{{tp|p=C7169335|t=2020. Promising methods for detection of novel coronavirus SARS?CoV?2 |pdf=|usr=}}
-{{tp|p=C7144506|t=2020. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition) |pdf=|usr=}}
-{{tp|p=32382657|t=2020. Assay Techniques and Test Development for COVID-19 Diagnosis |pdf=|usr=}}
 {{tp|p=32387093|t=2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target  sequences |pdf=|usr=}}
-{{ttp|p=32313543|t=2018. Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism |pdf=|usr=}}
-{{ttp|p=22174638|t=2011. Applications of Next-Generation Sequencing Technologies to Diagnostic Virology |pdf=|usr=}}
 {{tp|p=32378133|t=ä. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai, India |pdf=|usr=}}
-{{tp|p=C7184367|t=ä. COVID-19 in Pediatrics: A Laboratory Perspective |pdf=|usr=}}
 {{tp|p=32416598|t=2020. SARS-CoV-2 detection by direct rRT-PCR without RNA extraction |pdf=|usr=}}
-{{tp|p=32403010|t=2020. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies |pdf=|usr=}}
 {{tp|p=32388470|t=2020. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa? COVID-19 direct assay |pdf=|usr=}}
-{{tp|p=32403007|t=2020. Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic |pdf=|usr=}}
 {{tp|p=32403009|t=2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet |pdf=|usr=}}
 {{tp|p=32403008|t=2020. A RT-PCR assay for the detection of coronaviruses from four genera |pdf=|usr=}}
@@ Zeile 268: / Zeile 225: @@
 {{tp|p=32388471|t=2020. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for  rapid on-demand testing in the hospital setting |pdf=|usr=}}
-{{tp|p=32380382|t=2020. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays |pdf=|usr=}}
-{{tp|p=32388468|t=2020. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |pdf=|usr=}}
 {{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}}
-{{tp|p=C7194818|t=ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people |pdf=|usr=}}
 {{tp|p=32248474|t=2020. Vergessen Sie die Schnellteste auf Coronavirus!|pdf=|usr=}}
@@ Zeile 279: / Zeile 236: @@
 {{tp|p=32372836|t=2020. The problems with so-called immunity tests |pdf=|usr=}}
 {{tp|p=32376476|t=ä. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident |pdf=|usr=}}
-{{tp|p=C7197557|t=ä. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory |pdf=|usr=}}
-{{tp|p=32380210|t=2020. The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19 |pdf=|usr=}}
-{{tp|p=32330305|t=2020. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens |pdf=|usr=}}
 {{tp|p=32149770|t=2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction |pdf=|usr=}}
@@ Zeile 287: / Zeile 241: @@
 {{tp|p=32396505|t=2020. US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=007}}
-{{tp|p=32459137|t=2020. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.|pdf=|usr=007}}
 {{tp|p=32448084|t=2020. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets.|pdf=|usr=007}}
 {{tp|p=32438868|t=2020. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens.|pdf=|usr=007}}
-{{tp|p=32419639|t=2020. Viral loads in throat and anal swabs in children infected with SARS-CoV-2.|pdf=|usr=007}}
-{{tp|p=32492721|t=2020. COVID-19 Pandemic and Role of Human Saliva as a Testing Biofluid in Point-of-Care Technology.|pdf=|usr=007}}
 {{tp|p=32505692|t=2020. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.|pdf=|usr=007}}
 {{tp|p=32492531|t=2020. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.|pdf=|usr=007}}
-{{tp|p=32429101|t=2020. Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective.|pdf=|usr=007}}
-{{tp|p=32393482|t=2020. Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.|pdf=|usr=007}}
 {{tp|p=32505778|t=2020. Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19.|pdf=|usr=007}}
 {{tp|p=32512376|t=2020. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification.|pdf=|usr=007}}
-{{tp|p=32342925|t=2020. Challenges of Covid-19 testing.|pdf=|usr=007}}
-{{tp|p=32491306|t=2020. The different tests for the diagnosis of COVID-19 - A review in Brazil so far.|pdf=|usr=007}}
-{{tp|p=32486477|t=2020. Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen.|pdf=|usr=007}}
 {{tp|p=32459081|t=2020. Evaluacion de diferentes genes en la deteccion por RT-PCR del SARS-CoV-2 en muestras respiratorias y su evolucion en la infeccion.|pdf=|usr=007}}
-{{tp|p=32492294|t=2020. Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.|pdf=|usr=007}}
-{{tp|p=32466536|t=2020. Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis.|pdf=|usr=007}}
-{{tp|p=32395793|t=2020. SARS-CoV-2 infection virological diagnosis.|pdf=|usr=007}}
-{{tp|p=32400235|t=2020. The role of lower respiratory tract samples in the diagnosis of COVID-19.|pdf=|usr=007}}
 {{tp|p=32329388|t=2020. Positive RT-PCR test results after consecutively negative results in patients with COVID-19.|pdf=|usr=007}}
-{{tp|p=32384820|t=2020. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays.|pdf=|usr=007}}
-{{tp|p=32466458|t=2020. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.|pdf=|usr=007}}
 {{tp|p=32474555|t=2020. Evaluation of RdRp & ORF-1b-nsp14-based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study.|pdf=|usr=007}}
-{{tp|p=32456750|t=2020. Hospital infection and COVID-19: Do not put all your eggs on the "swab" tests.|pdf=|usr=007}}
 {{tp|p=32423519|t=2020. Screening for COVID-19: Patient Factors Predicting Positive PCR Test.|pdf=|usr=007}}
-{{tp|p=32321609|t=2020. Diagnostic Options for Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 {{tp|p=32449639|t=2020. SARS-CoV-2 RT-PCR: at least 2 viral targets are needed.|pdf=|usr=007}}
 {{tp|p=32420777|t=2020. Positive RT-PCR in urine from an asymptomatic patient with novel coronavirus 2019 infection: a case report.|pdf=|usr=007}}
-{{ttp|p=32302471|t=2020. How to Obtain a Nasopharyngeal Swab Specimen.|pdf=|usr=007}}
-{{tp|p=32463086|t=2020. Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children.|pdf=|usr=007}}
 {{tp|p=32501535|t=2020. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.|pdf=|usr=007}}
 {{tp|p=32484950|t=2020. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.|pdf=|usr=007}}
-{{tp|p=32401064|t=2020. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.|pdf=|usr=007}}
-{{tp|p=32427340|t=2020. Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs.|pdf=|usr=007}}
-{{tp|p=32397487|t=2020. Saliva-Friend and Foe in the COVID-19 Outbreak.|pdf=|usr=007}}
 {{tp|p=32475012|t=2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.|pdf=|usr=007}}
-{{tp|p=32511679|t=2020. The Laboratory Diagnosis of COVID-19-- Frequently-Asked Questions.|pdf=|usr=007}}
 {{tp|p=32506118|t=2020. Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.|pdf=|usr=007}}
 {{tp|p=32504529|t=2020. Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity?|pdf=|usr=007}}
-{{tp|p=32437513|t=2020. Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics.|pdf=|usr=007}}
-{{tp|p=32459192|t=2020. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.|pdf=|usr=007}}
 {{tp|p=32472672|t=2020. What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?|pdf=|usr=007}}
-{{tp|p=32442256|t=2020. Predicting infectious SARS-CoV-2 from diagnostic samples.|pdf=|usr=007}}
 {{tp|p=32435816|t=2020. To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value.|pdf=|usr=007}}
 {{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
-{{tp|p=32510339|t=2020. Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence.|pdf=|usr=007}}
-{{tp|p=32398230|t=2020. Interpreting a covid-19 test result.|pdf=|usr=007}}
-{{tp|p=32385433|t=2020. Saliva testing for COVID-19?|pdf=|usr=007}}
-{{tp|p=32472673|t=2020. Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.|pdf=|usr=007}}
-{{tp|p=32462195|t=2020. Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2.|pdf=|usr=007}}
-{{tp|p=32401598|t=2020. COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
-{{tp|p=32401535|t=2020. Reply to: COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
-{{tp|p=32420937|t=2020. Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
-{{tp|p=32420926|t=2020. Point-of-Care diagnostic of SARS-CoV-2: knowledge, attitudes, and perceptions (KAP) of medical workforce in Italy.|pdf=|usr=007}}
-{{tp|p=32506693|t=2020. Diagnosis of COVID-19 infection in children: less nasopharyngeal swabs, more saliva.|pdf=|usr=007}}
-{{tp|p=32501019|t=2020. 'Self-collected upper respiratory tract swabs for COVID-19 test': A feasible way to increase overall testing rate and conserve resources in South Africa.|pdf=|usr=007}}
-{{tp|p=32482077|t=2020. Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.|pdf=|usr=007}}
-{{tp|p=32455796|t=2020. Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis.|pdf=|usr=007}}
+{{tp|p=32401598|t=2020. COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
+{{tp|p=32401535|t=2020. Reply to: COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
-{{tp|p=32501021|t=2020. Community-based screening and testing for Coronavirus in Cape Town, South Africa: Short report.|pdf=|usr=007}}
-{{tp|p=32510340|t=2020. Diagnostic methods and potential portable biosensors for coronavirus disease 2019.|pdf=|usr=007}}
-{{ttp|p=32450754|t=2020. Inappropriate Nasopharyngeal Sampling for SARS-CoV-2 Detection Is a Relevant Cause of False-Negative Reports.|pdf=|usr=007}}
-{{tp|p=32407189|t=2020. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria.|pdf=|usr=007}}
-{{tp|p=32294815|t=2020. [Clinical observation on increasing the positive rate of novel coronavirus nucleic acid tests by sputum excretion induced by nebulizer therapy].|pdf=|usr=007}}
-{{tp|p=32385368|t=2020. First CRISPR test for the coronavirus approved in the United States.|pdf=|usr=007}}
-{{tp|p=32407257|t=2020. Assessing the Value of Diagnostic Tests in the New World of COVID-19 Pandemic.|pdf=|usr=007}}
-{{tp|p=32493981|t=2020. The COVID-19 testing debacle.|pdf=|usr=007}}
-{{tp|p=32358105|t=2020. Sniffing out Covid-19.|pdf=|usr=007}}
 {{tp|p=32270938|t=2020. Performance du frottis nasopharynge-PCR pour le diagnostic du Covid-19 - Recommandations pratiques sur la base des premieres donnees scientifiques.|pdf=|usr=007}}
-{{tp|p=32493791|t=2020. COVID-19 diagnostics in context.|pdf=|usr=007}}
-{{tp|p=32439785|t=2020. COVID-19 spotlights medical diagnostics.|pdf=|usr=007}}
-{{tp|p=32229604|t=2020. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.|pdf=|usr=007}}
 {{tp|p=32483586|t=2020. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.|pdf=|usr=007}}
-{{ttp|p=32404473|t=2020. Towards effective diagnostic assays for COVID-19: a review.|pdf=|usr=007}}
-{{tp|p=32198190|t=2020. Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore.|pdf=|usr=007}}
-{{tp|p=32435872|t=2020. Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics.|pdf=|usr=007}}
@@ Zeile 395: / Zeile 311: @@
 {{tp|p=32461285|t=2020. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.|pdf=|usr=007}}
 {{tp|p=32444354|t=2020. Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.|pdf=|usr=007}}
-{{tp|p=32414839|t=2020. Stability of SARS-CoV-2 in PBS for Molecular Detection.|pdf=|usr=007}}
-{{tp|p=32414838|t=2020. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.|pdf=|usr=007}}
-{{tp|p=32404481|t=2020. Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic.|pdf=|usr=007}}
@@ Zeile 403: / Zeile 316: @@
 {{tp|p=32381642|t=2020. Understanding, verifying and implementing Emergency Use Authorization molecular diagnostics for the detection of SARS-CoV-2 RNA.|pdf=|usr=007}}
 {{tp|p=32471894|t=2020. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution.|pdf=|usr=007}}
-{{tp|p=32467359|t=2020. Influence of Different Inactivation Methods on Severe Acute Respiratory Syndrome Coronavirus 2 RNA Copy Number.|pdf=|usr=007}}
-{{ttp|p=32502333|t=2020. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens.|pdf=|usr=007}}
-{{tp|p=32475066|t=2020. Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.|pdf=|usr=007}}
-{{tp|p=32361691|t=2020. Molecular diagnostics at the times of SARS-CoV-2 outbreak.|pdf=|usr=007}}
@@ Zeile 414: / Zeile 325: @@
-{{tp|p=32437124|t=2020. Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles.|pdf=|usr=008}}
 {{tp|p=32469511|t=2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?|pdf=|usr=008}}
@@ Zeile 420: / Zeile 331: @@
-{{tp|p=32487335|t=2020. Nasopharyngeal swab collection in the suspicion of Covid-19.|pdf=|usr=008}}
-{{tp|p=32427600|t=2020. Interpreting the COVID-19 Test Results: A Guide for Physiatrists.|pdf=|usr=008}}
-{{tp|p=32438806|t=2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.|pdf=|usr=008}}
-{{tp|p=32427657|t=2020. Can pediatric COVID-19 testing sensitivity be improved with sequential tests?|pdf=|usr=008}}
-{{tp|p=32496919|t=2020. Serodiagnostics for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.|pdf=|usr=008}}
-{{tp|p=32331789|t=2020. Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools.|pdf=|usr=008}}
+{{tp|p=32438806|t=2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.|pdf=|usr=008}}
-{{tp|p=32453605|t=2020. Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond.|pdf=|usr=008}}
 {{tp|p=32395391|t=2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.|pdf=|usr=008}}
-{{ttp|p=32419272|t=2020. Molecular Targets for the Testing of COVID-19.|pdf=|usr=008}}
-{{tp|p=32406424|t=2020. Covid-19: Why test? Who to test? How to test?|pdf=|usr=008}}
-{{tp|p=32533461|t=2020. Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19.|pdf=|usr=008}}
 {{tp|p=32387502|t=2020. Reduced Physical Activity During COVID-19 Pandemic in Children With Congenital Heart Disease.|pdf=|usr=008}}
 {{tp|p=32427226|t=2020. An automated Residual Exemplar Local Binary Pattern and iterative ReliefF based corona detection method using lung X-ray image.|pdf=|usr=008}}
-{{tp|p=32534909|t=2020. First detection of SARS-CoV-2 by real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in pleural fluid.|pdf=|usr=008}}
-{{tp|p=32518132|t=2020. Operationalizing COVID-19 testing: Who, what, when, where, why, and how.|pdf=|usr=008}}
 {{tp|p=32384153|t=2020. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ).|pdf=|usr=008}}
-{{tp|p=32485157|t=2020. Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?|pdf=|usr=008}}
@@ Zeile 449: / Zeile 350: @@
 {{tp|p=32422410|t=2020. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA.|pdf=|usr=008}}
-{{tp|p=32422408|t=2020. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.|pdf=|usr=008}}
 {{tp|p=32502646|t=2020. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.|pdf=|usr=008
 {{tp|p=32444479|t=2020. Incidental COVID-19 on PET/CT imaging.|pdf=|usr=008}}
-{{tp|p=32493742|t=2020. Diagnostic testing for SARS-CoV-2.|pdf=|usr=008}}
-{{tp|p=32483515|t=2020. What Do We Need to Know to Improve Diagnostic Testing Methods for the 2019 Novel Coronavirus?|pdf=|usr=008}}
-{{tp|p=32386354|t=2020. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?|pdf=|usr=008}}
+{{tp|p=32530490|t=2020. A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.|pdf=|usr=008}}
-{{tp|p=32383097|t=2020. Nasopharyngeal swabs during SARS-CoV-2 pandemic: a role for the otolaryngologist.|pdf=|usr=008}}
-{{tp|p=32530490|t=2020. A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.|pdf=|usr=008}}
-{{ttp|p=32535768|t=2020. COVID-19: molecular diagnostics overview.|pdf=|usr=008}}
@@ Zeile 494: / Zeile 383: @@
 {{tp|p=32489175|t=2020. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
-{{tp|p=32411619|t=2020. Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives.|pdf=|usr=008}}
 {{tp|p=32452225|t=2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.|pdf=|usr=008}}
-{{tp|p=32432217|t=2020. COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19.|pdf=|usr=008}}
-{{tp|p=32389155|t=2020. Utility of retesting for diagnosis of SARS-CoV-2/COVID-19 in hospitalized patients: Impact of the interval between tests.|pdf=|usr=008}}
-{{tp|p=32389132|t=2020. Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabs.|pdf=|usr=008}}
-{{tp|p=32532934|t=2020. COVID 19 diagnostic multiplicity and its role in community surveillance and control.|pdf=|usr=008}}
-{{tp|p=32344452|t=2020. Rapid detection of SARS-CoV-2 in saliva: can an endodontist take the lead in point-of-care COVID-19 testing?|pdf=|usr=008}}
-{{tp|p=32417248|t=2020. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.|pdf=|usr=008}}
-{{tp|p=32518072|t=2020. Culture-based virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19.|pdf=|usr=008}}
-{{tp|p=32522596|t=2020. Recent Advances in Molecular diagnosis curbing the COVID-19.|pdf=|usr=008}}
 {{tp|p=32535302|t=2020. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.|pdf=|usr=008}}
@@ Zeile 518: / Zeile 399: @@
-{{tp|p=32445839|t=2020. Clinical Testing For Covid-19.|pdf=|usr=008}}
 {{tp|p=32531884|t=2020. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.|pdf=|usr=008}}
 {{tp|p=32098019|t=2020. Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).|pdf=|usr=008}}
@@ Zeile 532: / Zeile 413: @@
 {{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}
-{{tp|p=32425660|t=2020. A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.|pdf=|usr=008}}
 {{tp|p=32535397|t=2020. Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR.|pdf=|usr=008}}
-{{tp|p=32361285|t=2020. Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays.|pdf=|usr=008}}
 {{tp|p=32344319|t=2020. Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples.|pdf=|usr=008}}
@@ Zeile 544: / Zeile 425: @@
 {{tp|p=32416600|t=2020. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.|pdf=|usr=008}}
-{{tp|p=32405257|t=2020. Validation of SARS-CoV-2 detection across multiple specimen types.|pdf=|usr=008}}
 {{tp|p=32405254|t=2020. Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories.|pdf=|usr=008}}
-{{tp|p=32381379|t=2020. Saliva samples as an alternative for novel coronavirus (COVID-19) diagnosis.|pdf=|usr=008}}
 {{tp|p=32446722|t=2020. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection.|pdf=|usr=008}}
 {{ttp|p=32173458|t=2020. Experience of different upper respiratory tract sampling strategies for detection of COVID-19.|pdf=|usr=008}}
@@ Zeile 554: / Zeile 435: @@
 {{tp|p=32473233|t=2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.|pdf=|usr=008}}
 {{tp|p=32473229|t=2020. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.|pdf=|usr=008}}
-{{tp|p=32504740|t=2020. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.|pdf=|usr=008}}
-{{tp|p=32534946|t=2020. Laboratory diagnosis of SARS-CoV-2 - A review of current methods.|pdf=|usr=008}}
-{{tp|p=32449329|t=2020. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva.|pdf=|usr=008}}
 {{tp|p=32383182|t=2020. Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?|pdf=|usr=008}}
 {{tp|p=32383179|t=2020. Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test.|pdf=|usr=008}}
-{{tp|p=32369202|t=2020. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR.|pdf=|usr=008}}
 {{tp|p=32401374|t=2020. Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.|pdf=|usr=008}}
-{{tp|p=32401343|t=2020. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.|pdf=|usr=008}}
-{{tp|p=32219885|t=2020. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.|pdf=|usr=008}}
-{{tp|p=32330297|t=2020. Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model.|pdf=|usr=008}}
-{{tp|p=32513617|t=2020. In vitro diagnostics of coronavirus disease 2019: Technologies and application.|pdf=|usr=008}}
-{{tp|p=32405270|t=2020. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.|pdf=|usr=008}}
-{{tp|p=32501315|t=2020. Au-decorated BN nanotube as a breathalyzer for potential medical applications.|pdf=|usr=008}}
 {{tp|p=32496708|t=2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?|pdf=|usr=008}}
 {{tp|p=32536002|t=2020. Pitfalls in SARS-CoV-2 PCR diagnostics.|pdf=|usr=008}}
-{{tp|p=32526372|t=2020. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.|pdf=|usr=008}}
-{{tp|p=32166939|t=2020. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]|pdf=|usr=008}}